DEEP Measures

DEEP Measures is a Helsinki-based health-tech company that provides a collaborative platform for the development and deployment of digital measures (digital biomarkers) in clinical trials. The company aims to standardize the fragmented process of digital measure development, bridging the gap between pharma, tech providers, and regulators to improve the quality and objectivity of clinical data. Originally incubated as an internal initiative at Johnson & Johnson, DEEP Measures became an independent company in 2024. Their platform offers a 'digital measure builder' and a collaborative ecosystem designed to help pharmaceutical companies and tech innovators accelerate drug development, enhance patient-centricity, and achieve regulatory success for digital endpoints.